Prognostic value of an integrated immune-inflammatory phenotype in surgically treated cervical cancer: survival modeling and immunohistochemical validation
Lin Ran, Zhaoan Lian, Yong Tian, Li Qin, Yingchun Xiang, Xiaohao Yan, Chengyu Shui · 2026
Read Prognostic value of an integrated immune-inflammatory phenotype in surgically treated cervical cancer: survival modeling and immunohistochemical validation by Lin Ran, Zhaoan Lian, Yong Tian, Li Qin, Yingchun Xiang, Xiaohao Yan, Chengyu Shui (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13314612.txt.
Description
Lin Ran and colleagues build a joint immune-inflammation score to sort relapse risk after cervical cancer surgery, in work published in 2026. Standard clinical traits miss how the tumor immune setting and body-wide inflammation shape who relapses after an operation.
The team studied 612 patients who had primary surgery from January 2020 to December 2025, as counted in the report. They graded immune cells in tumor stroma on stained slides and worked out a systemic immune-inflammation index from blood counts before treatment. Blending both gave three types: favorable, intermediate, and poor. Survival curves, flexible risk models, and adjusted hazard models tested the blend, and tissue staining checked the result. The joined score aims to flag high-risk women for closer watch or extra therapy.
Catalog record
| CREATOR | Lin Ran, Zhaoan Lian, Yong Tian, Li Qin, Yingchun Xiang, Xiaohao Yan, Chengyu Shui |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 55463 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |